ROM icon

ProShares Ultra Technology
ROM

Overview Fund Activity
85.62 USD
-0.16
0.19%
At close Updated Sep 12, 4:00 PM EDT
1 day
-0.19%
5 days
4.91%
1 month
1.21%
3 months
22.12%
6 months
52.27%
Year to date
23.62%
1 year
34.83%
5 years
207.99%
10 years
1,859.27%
0
Funds holding %
of 7,462 funds
–
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

300% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 4

54% more capital invested

Capital invested by funds: $41.3M [Q1] → $63.4M (+$22.1M) [Q2]

26% more funds holding

Funds holding: 47 [Q1] → 59 (+12) [Q2]

18% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 11

0.86% more ownership

Funds ownership: 7.6% [Q1] → 8.46% (+0.86%) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]

See Fund Rankings

Financial journalist opinion

Negative
Seeking Alpha
6 months ago
ROM: De-Risking Means De-Leveraging In Today's Environment
The market has shifted from consistent gains to increased volatility, signaling a potentially turbulent 2025, driven by factors like tariff news and economic uncertainty. Investors should proactively "de-risk" their portfolios by reducing leverage and high-beta investments, rather than reacting with "panic de-risking" during market downturns. The ProShares Ultra Technology ETF, a 2x leveraged technology fund, amplifies both gains and losses, making it particularly risky in a volatile market.
ROM: De-Risking Means De-Leveraging In Today's Environment
Neutral
Business Wire
9 months ago
Medincell and AIC Unveil New Positive Phase 3 Results for mdc-CWM: Major Subgroup Analysis Shows Reduced Pain and Opioid Use, and Accelerated Rehabilitation following Total Knee Replacement
MONTPELLIER, France--(BUSINESS WIRE)--Analysis of a major subgroup of patients undergoing a first Total Knee Replacement (TKR), representing over 70% of the trial population (108 out of 151), revealed the following benefits when comparing patients treated with F14/mdc-CWM (n=51) to those in the control group (n=57)1: 70% reduction in the number of opioid users at 3 months post-surgery, 28% reduction in the total quantity of opioids consumed during the first 3 months post-surgery, Lower daily kn.
Medincell and AIC Unveil New Positive Phase 3 Results for mdc-CWM: Major Subgroup Analysis Shows Reduced Pain and Opioid Use, and Accelerated Rehabilitation following Total Knee Replacement
Positive
Seeking Alpha
1 year ago
November Technology Dashboard, And The Risks Of ROM
Technology is the most overvalued sector, but the electronic equipment industry is undervalued relative to 11-year averages. 8 technology stocks were cheaper than their peers in November. ProShares Ultra Technology ETF: why the leveraged tech ROM ETF is risky.
See News Rankings
Charts implemented using Lightweight Charts™